RT Journal Article
SR Electronic
T1 Risk factors for severe complications and mortality in hospitalized children with measles during a major outbreak in Northern Vietnam, 2017 - 2019
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.07.16.23292745
DO 10.1101/2023.07.16.23292745
A1 Tran, Minh Dien
A1 Pham, Nhung T. H.
A1 Vu, Hoang Nguyen
A1 Tran, Minh-Hung
A1 Ngo, Hoang-Anh
A1 Phan, Phuc H
YR 2023
UL http://medrxiv.org/content/early/2023/07/17/2023.07.16.23292745.abstract
AB Introduction Measles outbreaks increased worldwide during the period of 2017-19. Similarly, Vietnam experienced one of the largest measles outbreaks in recent decades, with various paediatric patients presenting severe complications. In this study, we aim to identify factors associated with death and severity among children with measles admitted to Vietnam National Children’s Hospital between 2017 and 2019.Method This single-center retrospective cohort study included 2072 patients with measles admitted from 1/1/2017 to 31/12/2019. Data on epidemiological, clinical characteristics, vaccine status, and outcomes were collected and summarised. We conducted both univariable and multivariable logistic regression analyses to examine the correlations between various characteristics of hospitalized children and mortality.Findings In total, there were 2072 patients, including 1297 (62.6%) males and 775 (37.4%) females. The median age was 9 months (interquartile range 7 − 17). 87.3% of cases were reported not to have received any MCV. 30 (1.4%) patients died, with 40% aged less than 9 months. Only 3 among 30 (10%) children had received at least 1 dose of MCV deceased. Pneumonia bronchitis was the most common complication, occurring in 1413 (68.2%) patients. The following characteristics were significantly associated with mortality in the multivariable analysis: age under 9 months and age from 9 months to 5 years, residing 20 to 200 kilometres from VNCH, and having adenovirus or other healthcare-related infections. Age group was also significantly associated with severity in the multivariable analysis.Interpretation Vietnam continues to face the threat of future measles epidemics, given the burden of hospitalization and the high rate of complications observed in hospitalized patients. This highlights the critical need to maintain high measles vaccine coverage, particularly by targeting the unvaccinated population. To prevent future outbreaks and lower measles incidence, routine immunization needs to be strengthened, and earlier scheduling of MCV1 needs to be further evaluated. The comprehensive analysis of the 2017-19 measles outbreak presented in this study will contribute to informed decision-making regarding appropriate measures to counteract future resurgences of measles in Vietnam.Funding No specific grant from funding agencies in the public, commercial or not-for-profit sectors supported the submission and publication of this manuscript.Background and previous researchBetween 2017 and 2019, there was a global upsurge in measles outbreaks, and Vietnam witnessed one of the most substantial outbreaks in recent decades. To better understand the specific characteristics and impact of this outbreak in Vietnam, we conducted a thorough search for articles published between 2017 and 2022, focusing on this outbreak. However, our search revealed that none of the identified articles analyzed the socio-demographic and clinical data of individuals affected by measles during this particular outbreak in Vietnam, especially with the majority of patients concentrated in Northern Vietnam. This research aims to fill this gap and provide valuable insights into the sociodemographic and clinical aspects of the 2017 − 2019 measles outbreak in Vietnam.Significance of the studyOur research delved into the epidemiological and clinical characteristics of more than 2, 000 children who were hospitalized with measles at Vietnam National Children’s Hospital, the national paediatric referral hospital in Hanoi, from 2017 to 2019. Our analysis encompassed various aspects including admission date, age, sex, residence, exposure location, vaccination status, hospitalized duration, respiratory support, underlying conditions, complications, coinfections, and outcomes. We analysed associations with death and severed. Notably, our study went beyond mortality analysis and also focused on the severity of patients, which is a unique contribution. As a result, this comprehensive analysis offers a deeper understanding of measles cases, surpassing the insights provided by existing published data.Implications of the studyThis comprehensive analysis, including the largest number of individuals with measles in Vietnam, highlights the severity of a significant measles outbreak that accounted for 31.9% of the reported cases in the country from July 2017 to December 2019. The outbreak led to the unfortunate deaths of 30 children within the hospital alone, resulting in a mortality risk of 1.4%.Our analysis reveals that 97.6% of these deaths occurred in unvaccinated children. Considering the decline in measles vaccination coverage to 89% for the first dose of measles-containing vaccine (MCV1) in 2021, it is imperative to strengthen routine immunization efforts to prevent future outbreaks. Further research should be undertaken to identify the health system and cultural factors associated with vaccination latency in Vietnam.Our analysis showed that 40% of deaths occurred in children aged less than nine months, and 40% occurred between 6 months and 5 years. MCV1 first dose is not routinely given before nine months. We draw attention to one of the few previous trials of earlier vaccination and recommend that the measles vaccine schedule in low- and middle-income countries where maternal antibody levels may be low should be re-evaluated.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo specific grant from funding agencies in the public, commercial or not-for-profit sectors supported the submission and publication of this manuscript.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the Ethics Committee in Biomedical Research, Vietnam National Children's Hospital (Ref:473/BVNTW-HDDD, IRB identifier: IRB - VN01037/IRB00011976/FWA00028418). As the study involved a retrospective analysis of routinely collected data under strict anonymity, patient or caregiver consent was not required.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors.